[Experience in using the biologically active additive "miprovit" in the treatment of various metabolic diseases]

Area of Science:

• Nutrition Science
• Metabolic Health
• Obesity Research

Background:

• Obesity is a complex metabolic condition associated with elevated cholesterol and glucose levels.
• Increased atherogenicity poses a significant cardiovascular risk in individuals with obesity.
• Effective weight management strategies are crucial for improving patient health outcomes.

Purpose of the Study:

• To evaluate the impact of a protein and vitamin-enriched preparation, "Miprovit", on metabolic markers in patients with obesity.
• To assess the effects of "Miprovit" on appetite regulation and patient comfort during weight reduction.
• To investigate the efficacy of "Miprovit" in managing key indicators of metabolic syndrome.

Main Methods:

• A study involving 90 patients diagnosed with obesity.
• Administration of the protein and vitamin-enriched preparation "Miprovit".
• Monitoring of serum cholesterol, glucose levels, and coefficient of atherogenicity.
• Assessment of appetite, hunger, and patient-reported comfort during the treatment period.

Main Results:

• "Miprovit" demonstrated a significant decreasing effect on elevated serum cholesterol and glucose levels.
• The coefficient of atherogenicity was reduced in patients undergoing treatment with "Miprovit".
• Appetite and feelings of hunger decreased in 75% of patients, with improved comfort during weight reduction.

Conclusions:

• "Miprovit" is effective in improving metabolic parameters, including cholesterol and glucose levels, in obese patients.
• The preparation aids in appetite control and enhances patient comfort, facilitating weight management.
• "Miprovit" shows promise as a supportive agent in the comprehensive treatment of obesity and associated metabolic disturbances.